Form 4: DocGo Director Michael J. Burdiek Acquires 15,000 Shares of Common Stock

Director Michael J. Burdiek purchased 15,000 shares of DocGo Inc. common stock at $1.43 per share on May 15, 2025, increasing his direct holdings to 631,560 shares.

Summary

• On May 15, 2025, Michael J. Burdiek, a director of DocGo Inc., acquired 15,000 shares of the company's common stock.
• The purchase price was $1.43 per share.
• Following the transaction, Burdiek directly owns 631,560 shares of DocGo Inc. common stock.
• Burdiek also holds 34,965 restricted stock units (RSUs) that will vest on December 13, 2025, each representing the right to receive one share of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of RSUs on December 13, 2025, suggests continued alignment of the director's interests with the company's performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when company insiders, such as directors, buy or sell shares of their company's stock. It provides transparency to the market regarding insider transactions.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

DocGo Inc., Michael J. Burdiek, stock purchase, Form 4, director, common stock, beneficial ownership, RSUs